DASH DoorDash | $222.36 +1.0% | 8/20/2026 | | Boost Price Target | $205.00 ➝ $220.00 | Neutral | 00.00% | View details for Wedbush rating of DoorDash (NASDAQ:DASH) on 8/20/2026 |
WIX Wix.com | $82.39 +5.8% | 8/20/2026 | | Boost Price Target | $55.00 ➝ $80.00 | Neutral | 00.00% | View details for Wedbush rating of Wix.com (NASDAQ:WIX) on 8/20/2026 |
DUOL Duolingo | $147.03 +0.7% | 8/20/2026 | | Boost Price Target | $139.00 ➝ $150.00 | Neutral | 00.00% | View details for Wedbush rating of Duolingo (NASDAQ:DUOL) on 8/20/2026 |
EXPE Expedia Group | $324.17 -0.6% | 8/20/2026 | | Boost Price Target | $334.00 ➝ $417.00 | Outperform | 00.00% | View details for Wedbush rating of Expedia Group (NASDAQ:EXPE) on 8/20/2026 |
EBAY eBay | $104.61 +1.9% | 8/20/2026 | | Boost Price Target | $135.00 ➝ $137.00 | Outperform | 00.00% | View details for Wedbush rating of eBay (NASDAQ:EBAY) on 8/20/2026 |
CRTO Criteo | $17.49 -2.0% | 8/20/2026 | | Lower Price Target | $30.00 ➝ $25.00 | Outperform | 00.00% | View details for Wedbush rating of Criteo (NASDAQ:CRTO) on 8/20/2026 |
TLX Telix Pharmaceuticals | $12.42 +2.5% | 8/20/2026 | | Reiterated Rating | $22.00 | Outperform | 00.00% | View details for Wedbush rating of Telix Pharmaceuticals (NASDAQ:TLX) on 8/20/2026 |
AKTS Aktis Oncology | $24.00 -4.1% | 8/19/2026 | | Initiated Coverage | $35.00 | Outperform | 00.00% | View details for Wedbush rating of Aktis Oncology (NASDAQ:AKTS) on 8/19/2026 |
CLYM Climb Bio | $17.02 -1.8% | 8/19/2026 | | Reiterated Rating | $20.00 | Outperform | 00.00% | View details for Wedbush rating of Climb Bio (NASDAQ:CLYM) on 8/19/2026 |
ARDX Ardelyx | $3.90 -3.2% | 8/18/2026 | | Reiterated Rating | $9.00 | Outperform | 00.00% | View details for Wedbush rating of Ardelyx (NASDAQ:ARDX) on 8/18/2026 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
|
ARGX argenex | $1,038.12 +0.5% | 8/18/2026 | | Boost Price Target | $1,050.00 ➝ $1,150.00 | Outperform | 00.00% | View details for Wedbush rating of argenex (NASDAQ:ARGX) on 8/18/2026 |
RNAC Cartesian Therapeutics | $10.23 -2.5% | 8/18/2026 | | Reiterated Rating | $38.00 | Outperform | 00.00% | View details for Wedbush rating of Cartesian Therapeutics (NASDAQ:RNAC) on 8/18/2026 |
WLDN Willdan Group | $85.58 +0.9% | 8/18/2026 | | Reiterated Rating | $130.00 | Outperform | 00.00% | View details for Wedbush rating of Willdan Group (NASDAQ:WLDN) on 8/18/2026 |
IMUX Immunic | $16.10 -2.1% | 8/17/2026 | | Initiated Coverage | $45.00 | Outperform | 00.00% | View details for Wedbush rating of Immunic (NASDAQ:IMUX) on 8/17/2026 |
VERA Vera Therapeutics | $31.26 -3.2% | 8/17/2026 | | Reiterated Rating | $34.00 | Neutral | 00.00% | View details for Wedbush rating of Vera Therapeutics (NASDAQ:VERA) on 8/17/2026 |
GLOB Globant | $39.74 +0.6% | 8/14/2026 | | Downgrade | $54.00 ➝ $37.00 | Outperform ➝ Neutral | 00.00% | View details for Wedbush rating of Globant (NYSE:GLOB) on 8/14/2026 |
EIKN Eikon Therapeutics | $10.75 -10.5% | 8/14/2026 | | Lower Price Target | $5.00 ➝ $4.00 | Underperform | 00.00% | View details for Wedbush rating of Eikon Therapeutics (NASDAQ:EIKN) on 8/14/2026 |
FATE Fate Therapeutics | $2.45 -7.5% | 8/14/2026 | | Reiterated Rating | $7.00 | Outperform | 00.00% | View details for Wedbush rating of Fate Therapeutics (NASDAQ:FATE) on 8/14/2026 |
SNDK Sandisk | $1,600.62 +2.0% | 8/14/2026 | | Reiterated Rating | $2,000.00 | Outperform | 00.00% | View details for Wedbush rating of Sandisk (NASDAQ:SNDK) on 8/14/2026 |
ZBIO Zenas BioPharma | $31.62 +1.2% | 8/14/2026 | | Reiterated Rating | $45.00 | Outperform | 00.00% | View details for Wedbush rating of Zenas BioPharma (NASDAQ:ZBIO) on 8/14/2026 |
ANRO Alto Neuroscience | $34.22 -1.9% | 8/13/2026 | | Boost Price Target | $24.00 ➝ $26.00 | Neutral | 00.00% | View details for Wedbush rating of Alto Neuroscience (NYSE:ANRO) on 8/13/2026 |
BTGO BTGO | $6.59 +5.4% | 8/13/2026 | | Lower Price Target | $15.00 ➝ $8.00 | Outperform | 00.00% | View details for Wedbush rating of BTGO (NYSE:BTGO) on 8/13/2026 |
CBRS Cerebras Systems | $209.85 -2.7% | 8/13/2026 | | Boost Price Target | $280.00 ➝ $290.00 | Outperform | 00.00% | View details for Wedbush rating of Cerebras Systems (NASDAQ:CBRS) on 8/13/2026 |
CGEM Cullinan Therapeutics | $21.38 -5.1% | 8/13/2026 | | Boost Price Target | $39.00 ➝ $42.00 | Outperform | 00.00% | View details for Wedbush rating of Cullinan Therapeutics (NASDAQ:CGEM) on 8/13/2026 |
KURA Kura Oncology | $11.71 -6.5% | 8/13/2026 | | Boost Price Target | $36.00 ➝ $38.00 | Outperform | 00.00% | View details for Wedbush rating of Kura Oncology (NASDAQ:KURA) on 8/13/2026 |
STAA STAAR Surgical | $23.07 -6.4% | 8/13/2026 | | Lower Price Target | $40.00 ➝ $37.00 | Outperform | 00.00% | View details for Wedbush rating of STAAR Surgical (NASDAQ:STAA) on 8/13/2026 |
STRO Sutro Biopharma | $21.16 -3.4% | 8/13/2026 | | Reiterated Rating | $60.00 | Outperform | 00.00% | View details for Wedbush rating of Sutro Biopharma (NASDAQ:STRO) on 8/13/2026 |
TRAX First Tracks Biotherapeutics | $41.90 -7.9% | 8/13/2026 | | Boost Price Target | $60.00 ➝ $70.00 | Outperform | 00.00% | View details for Wedbush rating of First Tracks Biotherapeutics (NASDAQ:TRAX) on 8/13/2026 |
NCMI National CineMedia | $2.55 -3.4% | 8/12/2026 | | Set Price Target | $6.00 ➝ $5.00 | Outperform | 00.00% | View details for Wedbush rating of National CineMedia (NASDAQ:NCMI) on 8/12/2026 |
IMNM Immunome | $28.08 -5.9% | 8/12/2026 | | Boost Price Target | $31.00 ➝ $35.00 | Outperform | 00.00% | View details for Wedbush rating of Immunome (NASDAQ:IMNM) on 8/12/2026 |
COAG Hemab Therapeutics | $48.20 -6.7% | 8/12/2026 | | Boost Price Target | $55.00 ➝ $64.00 | Outperform | 00.00% | View details for Wedbush rating of Hemab Therapeutics (NASDAQ:COAG) on 8/12/2026 |
BCAX Bicara Therapeutics | $24.39 -5.7% | 8/12/2026 | | Boost Price Target | $30.00 ➝ $33.00 | Outperform | 00.00% | View details for Wedbush rating of Bicara Therapeutics (NASDAQ:BCAX) on 8/12/2026 |
ZURA Zura Bio | $5.75 -1.5% | 8/12/2026 | | Boost Price Target | $15.00 ➝ $22.00 | Outperform | 00.00% | View details for Wedbush rating of Zura Bio (NASDAQ:ZURA) on 8/12/2026 |
FENC Adherex Technologies | $11.35 -4.4% | 8/12/2026 | | Boost Price Target | $13.00 ➝ $16.00 | Outperform | 00.00% | View details for Wedbush rating of Adherex Technologies (NASDAQ:FENC) on 8/12/2026 |
SMCI Super Micro Computer | $36.50 -0.2% | 8/12/2026 | | Boost Price Target | $34.00 ➝ $40.00 | Neutral | 00.00% | View details for Wedbush rating of Super Micro Computer (NASDAQ:SMCI) on 8/12/2026 |
VOR Vor Biopharma | $23.07 -2.2% | 8/12/2026 | | Boost Price Target | $18.00 ➝ $27.00 | Neutral | 00.00% | View details for Wedbush rating of Vor Biopharma (NASDAQ:VOR) on 8/12/2026 |
ORKA Oruka Therapeutics | $104.86 -4.4% | 8/11/2026 | | Reiterated Rating | $165.00 | Outperform | 00.00% | View details for Wedbush rating of Oruka Therapeutics (NASDAQ:ORKA) on 8/11/2026 |
RCKT Rocket Pharmaceuticals | $3.48 -4.7% | 8/11/2026 | | Lower Price Target | $16.00 ➝ $15.00 | Outperform | 00.00% | View details for Wedbush rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 8/11/2026 |
VERA Vera Therapeutics | $31.26 -3.2% | 8/11/2026 | | Lower Price Target | $43.00 ➝ $34.00 | Neutral | 00.00% | View details for Wedbush rating of Vera Therapeutics (NASDAQ:VERA) on 8/11/2026 |
JBIO Jade Biosciences | $21.23 -5.9% | 8/10/2026 | | Boost Price Target | $45.00 ➝ $47.00 | Outperform | 00.00% | View details for Wedbush rating of Jade Biosciences (NASDAQ:JBIO) on 8/10/2026 |
Ready to give options a try? Your first trade (Ticker included) -INSIDE (Ad) Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and stinging losses? Dave Aquino is giving away the exact 11-hour options strategy he uses in volatile markets. You get the plain English blueprint behind the strategy and the very same "rinse and repeat" ticker he's traded nearly 900 times with a 95.3% success rate. It's so simple to understand, you could trade it tomorrow.
|
PTGX Protagonist Therapeutics | $150.69 -2.7% | 8/10/2026 | | Boost Price Target | $118.00 ➝ $173.00 | Outperform | 00.00% | View details for Wedbush rating of Protagonist Therapeutics (NASDAQ:PTGX) on 8/10/2026 |
SION Sionna Therapeutics | $5.52 -11.7% | 8/10/2026 | | Downgrade | $5.00 | Outperform ➝ Neutral | 00.00% | View details for Wedbush rating of Sionna Therapeutics (NASDAQ:SION) on 8/10/2026 |
SRRK Scholar Rock | $55.25 -2.2% | 8/10/2026 | | Reiterated Rating | $58.00 | Outperform | 00.00% | View details for Wedbush rating of Scholar Rock (NASDAQ:SRRK) on 8/10/2026 |
TTWO Take-Two Interactive Software | $240.15 +1.3% | 8/10/2026 | | Reiterated Rating | $300.00 | Outperform | 00.00% | View details for Wedbush rating of Take-Two Interactive Software (NASDAQ:TTWO) on 8/10/2026 |
REPL Replimune Group | $14.05 -5.1% | 8/7/2026 | | Upgrade | $12.00 | Neutral ➝ Outperform | 00.00% | View details for Wedbush rating of Replimune Group (NASDAQ:REPL) on 8/7/2026 |
ABNB Airbnb | $185.00 -0.7% | 8/7/2026 | | Upgrade | $152.00 ➝ $200.00 | Neutral ➝ Outperform | 00.00% | View details for Wedbush rating of Airbnb (NASDAQ:ABNB) on 8/7/2026 |
FRHC Freedom | $163.69 +2.9% | 8/6/2026 | | Set Price Target | $180.00 | | 00.00% | View details for Wedbush rating of Freedom (NASDAQ:FRHC) on 8/6/2026 |
FLUT Flutter Entertainment | $99.47 +0.3% | 8/6/2026 | | Lower Price Target | $138.00 ➝ $126.00 | Outperform | 00.00% | View details for Wedbush rating of Flutter Entertainment (NYSE:FLUT) on 8/6/2026 |
APP AppLovin | $308.77 -0.6% | 8/6/2026 | | Lower Price Target | $640.00 ➝ $610.00 | Outperform | 00.00% | View details for Wedbush rating of AppLovin (NASDAQ:APP) on 8/6/2026 |
TASK TaskUs | $7.76 -4.0% | 8/6/2026 | | Lower Price Target | $12.00 ➝ $9.00 | Outperform | 00.00% | View details for Wedbush rating of TaskUs (NASDAQ:TASK) on 8/6/2026 |
TVTX Travere Therapeutics | $64.46 -2.3% | 8/6/2026 | | Boost Price Target | $61.00 ➝ $75.00 | Outperform | 00.00% | View details for Wedbush rating of Travere Therapeutics (NASDAQ:TVTX) on 8/6/2026 |
RVMD Revolution Medicines | $211.74 -1.4% | 8/6/2026 | | Boost Price Target | $192.10 ➝ $201.00 | Outperform | 00.00% | View details for Wedbush rating of Revolution Medicines (NASDAQ:RVMD) on 8/6/2026 |
RCUS Arcus Biosciences | $29.61 -2.4% | 8/6/2026 | | Boost Price Target | $41.00 ➝ $43.00 | Outperform | 00.00% | View details for Wedbush rating of Arcus Biosciences (NYSE:RCUS) on 8/6/2026 |
BCRX BioCryst Pharmaceuticals | $9.66 -4.1% | 8/6/2026 | | Lower Price Target | $21.00 ➝ $20.00 | Outperform | 00.00% | View details for Wedbush rating of BioCryst Pharmaceuticals (NASDAQ:BCRX) on 8/6/2026 |
EBAY eBay | $104.61 +1.9% | 8/6/2026 | | Reiterated Rating | $135.00 | Outperform | 00.00% | View details for Wedbush rating of eBay (NASDAQ:EBAY) on 8/6/2026 |
EXPE Expedia Group | $324.17 -0.6% | 8/6/2026 | | Reiterated Rating | $334.00 | Outperform | 00.00% | View details for Wedbush rating of Expedia Group (NASDAQ:EXPE) on 8/6/2026 |
SHOP Shopify | $147.18 +0.4% | 8/6/2026 | | Boost Price Target | $155.00 ➝ $176.00 | Outperform | 00.00% | View details for Wedbush rating of Shopify (NASDAQ:SHOP) on 8/6/2026 |
SOLV Solventum | $88.65 +1.0% | 8/6/2026 | | Boost Price Target | $94.00 ➝ $101.00 | Outperform | 00.00% | View details for Wedbush rating of Solventum (NYSE:SOLV) on 8/6/2026 |
XNCR Xencor | $27.00 -1.9% | 8/6/2026 | | Boost Price Target | $26.00 ➝ $30.00 | Outperform | 00.00% | View details for Wedbush rating of Xencor (NASDAQ:XNCR) on 8/6/2026 |
IDYA IDEAYA Biosciences | $39.11 +0.6% | 8/5/2026 | | Boost Price Target | $58.00 ➝ $60.00 | Outperform | 00.00% | View details for Wedbush rating of IDEAYA Biosciences (NASDAQ:IDYA) on 8/5/2026 |
ARVN Arvinas | $9.02 -6.8% | 8/5/2026 | | Boost Price Target | $11.00 ➝ $12.00 | Neutral | 00.00% | View details for Wedbush rating of Arvinas (NASDAQ:ARVN) on 8/5/2026 |
AMD Advanced Micro Devices | $469.45 +0.6% | 8/5/2026 | | Reiterated Rating | $600.00 | Outperform | 00.00% | View details for Wedbush rating of Advanced Micro Devices (NASDAQ:AMD) on 8/5/2026 |
BKNG Booking | $209.87 -1.5% | 8/5/2026 | | Boost Price Target | $211.00 ➝ $247.00 | Outperform | 00.00% | View details for Wedbush rating of Booking (NASDAQ:BKNG) on 8/5/2026 |
DNTH Dianthus Therapeutics | $109.51 -3.7% | 8/5/2026 | | Boost Price Target | $105.00 ➝ $122.00 | Outperform | 00.00% | View details for Wedbush rating of Dianthus Therapeutics (NASDAQ:DNTH) on 8/5/2026 |
LRMR Larimar Therapeutics | $4.16 -2.1% | 8/5/2026 | | Lower Price Target | $12.00 ➝ $11.00 | Outperform | 00.00% | View details for Wedbush rating of Larimar Therapeutics (NASDAQ:LRMR) on 8/5/2026 |
PINS Pinterest | $23.18 -0.9% | 8/5/2026 | | Reiterated Rating | $24.00 | Neutral | 00.00% | View details for Wedbush rating of Pinterest (NYSE:PINS) on 8/5/2026 |
SYRE Spyre Therapeutics | $107.79 -1.0% | 8/5/2026 | | Boost Price Target | $100.00 ➝ $130.00 | Outperform | 00.00% | View details for Wedbush rating of Spyre Therapeutics (NASDAQ:SYRE) on 8/5/2026 |
W Wayfair | $103.41 -4.1% | 8/5/2026 | | Boost Price Target | $85.00 ➝ $125.00 | Neutral | 00.00% | View details for Wedbush rating of Wayfair (NYSE:W) on 8/5/2026 |
SKHY SK hynix | $163.08 +4.4% | 8/4/2026 | | Upgrade | | Strong-Buy | 00.00% | View details for Wedbush rating of SK hynix (NASDAQ:SKHY) on 8/4/2026 |
STAA STAAR Surgical | $23.07 -6.4% | 8/4/2026 | | Reiterated Rating | $40.00 | Outperform | 00.00% | View details for Wedbush rating of STAAR Surgical (NASDAQ:STAA) on 8/4/2026 |
STOK Stoke Therapeutics | $31.40 -4.9% | 8/4/2026 | | Boost Price Target | $38.00 ➝ $40.00 | Outperform | 00.00% | View details for Wedbush rating of Stoke Therapeutics (NASDAQ:STOK) on 8/4/2026 |
CRSR Corsair Gaming | $10.91 -3.9% | 8/3/2026 | | Boost Price Target | $8.00 ➝ $13.00 | Outperform | 00.00% | View details for Wedbush rating of Corsair Gaming (NASDAQ:CRSR) on 8/3/2026 |
GDDY GoDaddy | $98.09 +1.3% | 8/3/2026 | | Lower Price Target | $109.00 ➝ $93.00 | Outperform | 00.00% | View details for Wedbush rating of GoDaddy (NYSE:GDDY) on 8/3/2026 |
GLUE Monte Rosa Therapeutics | $14.78 -6.3% | 8/3/2026 | | Lower Price Target | $37.00 ➝ $27.00 | Outperform | 00.00% | View details for Wedbush rating of Monte Rosa Therapeutics (NASDAQ:GLUE) on 8/3/2026 |
INFQ Infleqtion | $12.46 -0.3% | 8/3/2026 | | Initiated Coverage | $20.00 | Outperform | 00.00% | View details for Wedbush rating of Infleqtion (NYSE:INFQ) on 8/3/2026 |
IONQ IonQ | $41.57 -4.1% | 8/3/2026 | | Initiated Coverage | $75.00 | Outperform | 00.00% | View details for Wedbush rating of IonQ (NYSE:IONQ) on 8/3/2026 |
NBIX Neurocrine Biosciences | $152.93 -1.7% | 8/3/2026 | | Boost Price Target | $185.00 ➝ $194.00 | Outperform | 00.00% | View details for Wedbush rating of Neurocrine Biosciences (NASDAQ:NBIX) on 8/3/2026 |
PLTK Playtika | $2.35
| 8/3/2026 | | Boost Price Target | $3.00 ➝ $4.00 | Neutral | 00.00% | View details for Wedbush rating of Playtika (NASDAQ:PLTK) on 8/3/2026 |
QBTS D-Wave Quantum | $18.80 -2.7% | 8/3/2026 | | Initiated Coverage | $40.00 | Outperform | 00.00% | View details for Wedbush rating of D-Wave Quantum (NASDAQ:QBTS) on 8/3/2026 |
QUBT Quantum Computing | $8.14 -3.3% | 8/3/2026 | | Initiated Coverage | $12.00 | Neutral | 00.00% | View details for Wedbush rating of Quantum Computing (NASDAQ:QUBT) on 8/3/2026 |
RGTI Rigetti Computing | $16.07 -5.5% | 8/3/2026 | | Initiated Coverage | $40.00 | Outperform | 00.00% | View details for Wedbush rating of Rigetti Computing (NASDAQ:RGTI) on 8/3/2026 |
CNK Cinemark | $37.01 -0.8% | 7/31/2026 | | Boost Price Target | $40.00 ➝ $43.00 | Outperform | 00.00% | View details for Wedbush rating of Cinemark (NYSE:CNK) on 7/31/2026 |
REPL Replimune Group | $14.05 -5.1% | 7/31/2026 | | Upgrade | $9.00 ➝ $12.00 | Neutral ➝ Outperform | 00.00% | View details for Wedbush rating of Replimune Group (NASDAQ:REPL) on 7/31/2026 |
AMZN Amazon.com | $259.92 -2.2% | 7/31/2026 | | Boost Price Target | $293.00 ➝ $310.00 | Outperform | 00.00% | View details for Wedbush rating of Amazon.com (NASDAQ:AMZN) on 7/31/2026 |
FMCC Freddie Mac | $5.62 -3.0% | 7/31/2026 | | Initiated Coverage | $12.00 | Outperform | 00.00% | View details for Wedbush rating of Freddie Mac (OTCMKTS:FMCC) on 7/31/2026 |
MCS Marcus | $29.60 -2.5% | 7/31/2026 | | Boost Price Target | $23.00 ➝ $34.00 | Outperform | 00.00% | View details for Wedbush rating of Marcus (NYSE:MCS) on 7/31/2026 |
RBLX Roblox | $38.52 -0.4% | 7/31/2026 | | Downgrade | $65.00 ➝ $40.00 | Outperform ➝ Neutral | 00.00% | View details for Wedbush rating of Roblox (NYSE:RBLX) on 7/31/2026 |
RDDT Reddit | $150.31 -0.9% | 7/31/2026 | | Lower Price Target | $250.00 ➝ $221.00 | Outperform | 00.00% | View details for Wedbush rating of Reddit (NYSE:RDDT) on 7/31/2026 |
WVE WAVE Life Sciences | $5.25 -3.0% | 7/31/2026 | | Lower Price Target | $15.00 ➝ $12.00 | Outperform | 00.00% | View details for Wedbush rating of WAVE Life Sciences (NASDAQ:WVE) on 7/31/2026 |
META Meta Platforms | $545.83 0.0% | 7/30/2026 | | Lower Price Target | $671.00 ➝ $595.00 | Neutral | 00.00% | View details for Wedbush rating of Meta Platforms (NASDAQ:META) on 7/30/2026 |
The REAL Reason Trump is Invading Iran (Ad) For a moment…
Forget about Trump’s ties to Israel.
Forget about reports of Iran’s nuclear program.
Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason. Click here to find out what it is. |
BIIB Biogen | $214.35 -3.3% | 7/30/2026 | | Boost Price Target | $201.00 ➝ $215.00 | Neutral | 00.00% | View details for Wedbush rating of Biogen (NASDAQ:BIIB) on 7/30/2026 |
DMRA Damora Therapeutics, Inc. Common Stock | $30.31 -6.6% | 7/30/2026 | | Boost Price Target | $35.00 ➝ $40.00 | Outperform | 00.00% | View details for Wedbush rating of Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA) on 7/30/2026 |
FNMA Fannie Mae | $6.19 -1.7% | 7/30/2026 | | Reiterated Rating | $8.00 | Neutral | 00.00% | View details for Wedbush rating of Fannie Mae (OTCMKTS:FNMA) on 7/30/2026 |
XNCR Xencor | $27.00 -1.9% | 7/30/2026 | | Reiterated Rating | $26.00 | Outperform | 00.00% | View details for Wedbush rating of Xencor (NASDAQ:XNCR) on 7/30/2026 |
CNK Cinemark | $37.01 -0.8% | 7/29/2026 | | Boost Price Target | $37.00 ➝ $40.00 | Outperform | 00.00% | View details for Wedbush rating of Cinemark (NYSE:CNK) on 7/29/2026 |
KNSA Kiniksa Pharmaceuticals International | $78.47 -2.9% | 7/29/2026 | | Boost Price Target | $72.00 ➝ $99.00 | Outperform | 00.00% | View details for Wedbush rating of Kiniksa Pharmaceuticals International (NASDAQ:KNSA) on 7/29/2026 |
LOGI Logitech International | $95.34 -5.1% | 7/29/2026 | | Lower Price Target | $135.00 ➝ $130.00 | Outperform | 00.00% | View details for Wedbush rating of Logitech International (NASDAQ:LOGI) on 7/29/2026 |
RPT Rithm Property Trust | $13.16 +0.8% | 7/29/2026 | | Upgrade | | Strong-Buy | 00.00% | View details for Wedbush rating of Rithm Property Trust (NYSE:RPT) on 7/29/2026 |
STX Seagate Technology | $850.24 +2.1% | 7/29/2026 | | Boost Price Target | $825.00 ➝ $1,000.00 | Outperform | 00.00% | View details for Wedbush rating of Seagate Technology (NASDAQ:STX) on 7/29/2026 |
GDDY GoDaddy | $98.09 +1.3% | 7/28/2026 | | Reiterated Rating | | Outperform | 00.00% | View details for Wedbush rating of GoDaddy (NYSE:GDDY) on 7/28/2026 |